Cello preclosing trading update

Cello, the insight and strategic marketing group, today publishes the following trading update for the year ended 31 December 2013.


– Strong trading for the year, revenues and headline profit before tax ahead of consensus market expectations

– Cello Health delivers double digit revenue growth and maintains 20% operating margin

– Cello Consumer delivers double digit revenue growth and restores double digit operating margin

– Very strong cash conversion, reducing net debt to below expected levels

– Growth investments in healthcare ventures prove successful in first year

– Good new business pipeline in Q4 2013 underpins solid start to 2014

– Group rebranding initiatives proceeding to plan

For the full RNS click Cello